• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR TREK CORONARY DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR TREK CORONARY DILATATION CATHETER Back to Search Results
Model Number 1012272-20
Medical Device Problem Codes Deflation Problem (1149); Improper or Incorrect Procedure or Method (2017); Difficult to Advance (2920)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/18/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the procedure was to treat a moderately calcified, 80-99% stenosed lesion in the mid anterior interventricular artery (iva).A 2.5x20mm trek rx balloon dilatation catheter (bdc) was advanced to the target lesion for pre-dilatation.The initial inflation was to 14 atmospheres (atm) and held for 14 seconds.The bdc was then moved a few millimeters to pre-dilatate a more proximal part of the lesion when resistance was noted.The second inflation was to 20 atm and held for 10 seconds.Subsequently, imaging was performed, and it was noted that the balloon only partially deflated.The balloon was able to be successfully removed from the anatomy while it was partially inflated.There was no adverse patient effect and no clinically significant delay in the procedure.
 
Additional Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
H6 medical device problem code 2017 clarifier above rbp.Visual, dimensional and functional inspections were performed on the returned device.The reported deflation issue could not be confirmed as the device deflated without issue, per manufacturing specifications.The reported difficulty advancing the device could not be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no other similar incidents/complaints from this lot.It was reported that during the second inflation, the bdc was overinflated to 20 atmospheres (atms).It should be noted that the coronary dilatation catheters (cdc), trek rx global, instruction for use (ifu) states: balloon pressure should not exceed the rated burst pressure (rbp).The rbp for the trek rx device is 14 atm; therefore, rbp was exceeded.In this case, it is unknown if the violation caused or contributed to the reported complaint.The investigation was unable to determine a conclusive cause for the reported deflation issue; however, the reported difficulty advancing the device appears to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
 
Event or Problem Description
Subsequent to the initial report, the following information was received: after the initial inflation, the bdc was not fully deflated, but was moved a few millimeters to pre-dilatate a more proximal part of the lesion when resistance was noted.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREK CORONARY DILATATION CATHETER
Common Device Name
CORONARY DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14075355
Report Number2024168-2022-03872
Device Sequence Number2570273
Product Code LOX
UDI-Device Identifier08717648138300
UDI-Public08717648138300
Combination Product (Y/N)N
Initial Reporter CountryBE
PMA/510(K) Number
K103110
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2024
Device Model Number1012272-20
Device Catalogue Number1012272-20
Device Lot Number11027G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/21/2022
Supplement Date Received by Manufacturer06/15/2022
Initial Report FDA Received Date04/11/2022
Supplement Report FDA Received Date06/22/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/27/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-